Top 3 Anti aging Therapeutics for Dog Companies

Published: April 2026

Aging is a multifactorial biological phenomenon which is characterized by a decline in physiological functions and adaptability. This decline results in the reduced ability of aging organisms to respond to environmental changes and stressors, leading to reduced efficiency in metabolic, immune, and hormonal functions.

There are several symptoms which characterize aging in dogs, including both physical and behavioral changes. It is important to highlight that some symptoms are a normal part of aging, while others may indicate underlying health problems that require veterinary attention. It is worth highlighting that the Dog Aging Project (DAP) was initiated in 2019 by the University of Washington and Texas A&M University with support from the National Institute on Aging (NIA). This is a pioneering, long-term longitudinal study designed to identify the genetic, lifestyle, and environmental factors that affect canine's lifespan.

In order to investigate the new pathophysiological pathways for the identification of dogs translatable biomarkers and increase the success rate in drug development, various technologies are being integrated, including next-generation sequencing, omics analysis and artificial intelligence, with the ability to manage aging in dogs.

Roots Analysis has conducted an exhaustive study on Anti aging Therapeutics for Dogs Market featuring the current market landscape and future opportunity for companies engaged in healthcare, over a span of next 10 years.

Top Three Anti aging Therapeutics for Dogs Companies

Genflow Bioscience
Loyal
Telomir Pharmaceuticals

The figure below highlights the top three anti aging therapeutics for dogs developers:

top 3 Anti-aging Therapeutics for Dog Companies

Interested in exploring players engaged in the development of drugs to manage anti aging in dogs, along with their recent initiatives?

Discover Below the Details on Top 3 Anti aging Therapeutics for Dogs Developers

Let us dive deep into the details of the top 3 anti aging therapeutics for dogs developers. It is essential to note that the selection of top players can differ substantially according to the defined criteria.

Genflow Bioscience

Company Overview

Genflow Bioscience is a UK-based firm focused on developing anti aging therapeutics for both humans as well as dogs. The company’s primary aim is to treat aging by targeting age-related diseases.

It is important to highlight that Genflow Bioscience employs advanced gene delivery techniques to introduce additional copies of the SIRT6 gene and regulate the aging process. Further, this technique uses adeno-associated virus (AAV) vectors for safe, non-integrative gene delivery, which has shown promising preclinical results in epigenetic tissue rejuvenation. According to the company’s website it has established research and development facilities in Belgium.

Recent Developments

In February 2026, Genflow Bioscience announced positive preliminary interim results from its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial evaluating its proprietary SIRT6 centenarian gene therapy in aged dogs.

To know more about the recent initiatives of Genflow Bioscience and other anti aging therapeutics for dogs companies, access full report.

Loyal

Company Overview

Loyal is engaged in developing anti aging therapeutics for dogs with an aim to target the root causes of various age-related diseases. Notably, the company is aiming to launch the first FDA-approved longevity drug, targeting age-associated diseases and metabolic dysfunction in senior and large-breed dogs.

Recent Developments

It is worth highlighting that in February 2026, Loyal’s lead candidate LOY-002, received funding of USD 100 million through venture capital series C with the aim to advance its first longevity drug.

To know more about the recent initiatives of Loyal and other anti aging therapeutics for dogs companies, access full report.

Telomir Pharmaceuticals

Company Overview

Telomir Pharmaceuticals is a US-based firm, focused on the development of age-reversal and longevity therapies by targeting biological processes accelerating aging and chronic diseases. Further, the company’s scientific approach relies on modulating metal ion imbalances and protecting genomic stability and processes that are involved in the progression of cancer, neurodegenerative disorders, and other age-related conditions.

As per the recent preclinical studies, Telomir-1 may help restore neurological, liver, and kidney function in models of Wilson’s disease and further show promising results in reducing oxidative stress and reversing cell aging in Progeria and age-related macular degeneration

Recent Developments

In the recent year, Telomir Pharmaceutical secured USD 3 million in equity financing to support the advancement of its anti aging therapeutics for dogs pipeline portfolio.

To know more about the recent initiatives of Telomir Pharmaceutical and other anti aging therapeutics for dogs companies, access full report.

What About Other Anti aging Therapeutics for Dogs Developers Around the World?

The above article features the top three anti aging therapeutics for dogs companies selected from a pool of companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.

Sources: